Novel Camptothecin Linker-Payloads for High-Efficacy Antibody-Drug Conjugates

A discovery chemistry campaign describes novel camptothecin-based linker-payloads for antibody-drug conjugates (ADCs). The dataset, created by Vlad Bacauanu and last updated in April 2026, likely contains results from the synthesis and evaluation of cytotoxic analogs and optimized linkers. It includes data on constructs enabling high drug-to-antibody ratio ADCs with good biophysical properties and in vivo efficacy.

Use Cases

• Evaluating in vitro potency of amine-containing cytotoxic analogs based on exatecan.
• Analyzing the stability and polarity of optimized protease-cleavable PABC linkers.
• Comparing the in vivo target-mediated efficacy of high-DAR ADCs across different antibody-antigen pairs.
• Assessing biophysical properties like aggregation for novel linker-payload constructs.

Strengths

• Dataset is focused on a specific, rational design strategy for novel camptothecin linker-payloads.
• The description mentions evaluation across multiple criteria: potency, permeability, stability, polarity, and in vivo efficacy.

Limitations

• The dataset is very small at 2.7 KB, indicating limited scope and likely a summary or key results only.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for statistical modeling.

Provenance

Source

figshare

Collection Method

Likely contains experimental results from a synthetic chemistry and biological evaluation campaign.

Freshness

Last updated 2026-04-30 10:04:05; freshness should be verified.